Rescheduling marijuana: The good, the bad and the ugly unknowns of Schedule II: We know the Drug Enforcement Administration is thinking about rescheduling marijuana. But we don’t know what will happen to the way we regulate all things marijuana — and America’s existing cannabis industry, too — if the drug is rescheduled from Schedule I to Schedule II, as some predict will happen. –Report by The Cannabist’s Ricardo Baca

CBD research for NFL players quickly gaining traction: Interest in a campaign for cannabidiol (CBD) research for NFL players continues to grow. The movement that started in Colorado and has gained steam with the backing of offensive tackle Eugene Monroe, former Bronco Jake Plummer and, most recently, Titans linebacker Derrick Morgan, has reached the NFL Players Association. About a week after speaking with two NFL officials about the studies, Dr. Marcel Bonn-Miller, a professor of psychology at the University of Pennsylvania’s Perelman School of Medicine, said he spoke with Nyaka Niilampti, the union’s director of player wellness. Like the NFL, the NFLPA also initiated conversations with Bonn-Miller to discuss the parameters of the studies and to learn of the research that has been done on CBD. –Report by The Denver Post’s Nicki Jhabvala